APYX
Apyx Medical·NASDAQ
--
--(--)
--
--(--)
3.47 / 10
Netural
Capital flows are healthy (6.94/10) with positive trends across small, medium, and extra-large orders; only large-block flows show a slight pullback. Analyst sentiment is sparse—only one active analyst with a Strong Buy rating—yet the consensus is overwhelmingly bullish in theory. However, the neutral overall sentiment score (3.47) reflects thin coverage and limited historical win-rate data, so conviction remains moderate.
Fund Flow Rating
Analyst RatingStrong Buy
Wall Street Opinions
Strong Buy
Strong Buy
100%
Buy
0%
Hold
0%
Sell
0%
Strong Sell
0%
Date2025-12-16
InstitutionRoth Capital
Times predicted1
Historical Win Rate0.0%
What is the market sentiment for APYX?
- APYX holds a Bearish analyst rating, with 100% of experts assigning a Strong Buy grade. Factoring in net Inflows from order flow data, the comprehensive Sentiment Score stands at 3.47/10 (Netural).
